Re:Trump Sends Pharma Stocks Down with New Tweet on Drug Prices
by FireBeyond on Tuesday March 07, 2017 @12:50PM
(#13812725)
When a quarter of their revenue goes on sales and marketing that is pretty subjectively "unnecessary" I don't they can claim with a straight face that it's "subsidizing the world". Especially when they're already making $14B a year in profit, in J&J's case.
Re:Trump Sends Pharma Stocks Down with New Tweet on Drug Prices
by cmdrfred on Tuesday March 07, 2017 @12:56PM
(#13812789)
Also if the risk is so high why are drug companies so profitable over the long term? Pharma firms are head and shoulders the most profitable firms in the S&P 500 every single year.
Re:Trump Sends Pharma Stocks Down with New Tweet on Drug Prices
by akiselev on Tuesday March 07, 2017 @01:28PM
(#13813129)
High risk, high reward. Why would anyone take a higher risk for a lower reward?
Pharmaceutical companies in the S&P500 are so profitable because of barriers to entry, massive capital requirements, and a whole biotechnology industry feeding them acquisitions. Biotech startups going under with zero revenue after raising hundreds of millions of dollars from VCs and institutional investors is a regular occurrence. Since the brunt of the pure research is publicly funded and other investors chasing ROI take care of much of the R&D risk, big pharma companies benefit a lot from other people's money just for providing exit opportunities for smaller companies.
Basically, because the US is wealthy and much less regulated, drug companies from around the world make up a lot of their costs by selling things for more here, especially since private insurers have to pick up the tab in most cases.